<?xml version="1.0" encoding="UTF-8"?>
<ref id="R50">
 <label>50</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <string-name>
    <surname>Parikh</surname>
    <given-names>NR</given-names>
   </string-name>, 
   <string-name>
    <surname>Huiza</surname>
    <given-names>C</given-names>
   </string-name>, 
   <string-name>
    <surname>Patel</surname>
    <given-names>JS</given-names>
   </string-name>, 
   <etal>et al</etal>
  </person-group>. 
  <article-title>Systemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic disease</article-title>. 
  <source>BMC Cancer</source>
  <year>2019</year>;
  <volume>19</volume>:
  <fpage>1</fpage>â€“
  <lpage>6</lpage>. 
  <pub-id pub-id-type="doi">10.1186/s12885-019-5496-5</pub-id>
  <pub-id pub-id-type="pmid">30606139</pub-id>
 </mixed-citation>
</ref>
